Description: Zoono Group Limited, formerly Goldsearch Limited, is an Australia-based company, engaged in the development, manufacture and global distribution of antimicrobial solutions. The Company has developed Zoono Molecule. Zoono Molecule is an antimicrobial that bonds to any surface, including hard surfaces, textiles, fabrics, and skin. Zoono Molecule kills pathogens, including bacteria, viruses, algae, fungi and mould. Its products include Hand Sanitiser GermFree24, Zoono SkinClear, Zoono Foot Guard, Odor Guard, Bathroom Microbe Shield, Kitchen Microbe Shield, Sport Microbe Shield, All Purpose Microbe Shield, Wet Wipes, Zoono Z-71 Surface Sanitiser, ZoonoTex Z-35 Textile Treatment, Zoono Deodorant, Zoono Mould Guard, Zoono Ultra, Zoono Aerosol, Zoono Room Sanitiser and Deodoriser, and Zoono Femme Hygiene. The Company’s products are applied in areas, including hospitals, medical facilities, laboratories, veterinary, homes, poultry and food processing.
Home Page: zoono.com
ZNO Technical Analysis
24 Bishop Dunn Place
Auckland,
2013
New Zealand
Phone:
64 2 165 9977
Officers
| Name | Title |
|---|---|
| Mr. Barry Woolcott | Group Chief Exec. Officer |
| Mr. Paul Ravlich CA, MBA | Chief Financial Officer |
| Mr. Lewis Andrew Craig MacKinnon | Chief Operating Officer |
| Mr. Paul Hyslop | MD & Director |
| Ms. Elissa C. Hansen ACSA, B.Com., B.Comm, FCIS, Gad Dip ACG, GAICD | Company Sec. & Independent Non-Exec. Director |
| Mr. Brad Camac | Sr. VP of Sales - Los Angeles, California, USA |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.6337 |
| Price-to-Sales TTM: | 1.8516 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |